Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

  • There is currently no data for GUS

Final Results

28 Sep 2012 07:00

RNS Number : 3961N
Shellproof Limited
28 September 2012
Β 

Β 

Β 

Β 

Β 

Β 

Shellproof Limited announces results for the year ended 31 March 2012

Β 

Belize City, Belize, 28 September 2012 - Shellproof Limited (London-AIM: SHLP) ("Shellproof" or the "Company") reported a net profit of β‚€9,000 for the year ended 31 March 2012 (2011 - β‚€104,000). Basic and diluted earnings per ordinary share for the year ended 31 March 2012 amounted to 0.11 pence (2011 - 1.30 pence).

During the year ended 31 March 2012, the Company established a wholly-owned UK subsidiary company to carry out a trial production of sparkling wine in order to explore the potential of this business sector for investment. To date, approximately Β£250,000 has been incurred in this activity.

The Company continues its search for further investment opportunities in line with its stated strategy which includes possible investment in either one or more quoted or unquoted businesses that may have been set up by entrepreneurs with good strategic plans and need financial backing and the support of the experienced Shellproof management team.

The Board notes that, as of the date of this announcement, the shares of Shellproof trade on AIM at an approximate 16% discount to the Company's net asset value.

The annual report of the Company is being sent to shareholders today.

Further details are set out on the Company's web site.

Β 

For further information contact:

Β 

Shellproof Limited

Belize +501 223 5989

UK +44 (0)20 7248 6700

Β 

Note: This and other press releases are available at the Company's web site: http://www.shellprooflimited.com.Β 

Β 

Β 

Β 

Β Income statement

Β 

Β 

Year ended 31 March

2012

2011

UKβ‚€000

UKβ‚€000

Administrative expenses

(143)

(65)

Operating loss

(143)

(65)

Financial income

152

169

Profit before taxation

9

104

Taxation

-

-

Net profit for the year

9

104

Earnings per ordinary share

Basic and diluted (pence)

0.11

1.30

Β 

Β 

Β 

Β 

Β 

Β 

Β Balance sheet

Β 

Β 

At 31 March

2012

2011

UKβ‚€000

UKβ‚€000

Assets

Non-current assets

Property, plant and equipment

68

-

Current assets

Cash and cash equivalents

4,123

4,257

Stocks

84

-

Other receivables

20

19

4,227

4,276

Liabilities

Current liabilities

Other payables

(24)

(14)

Net current assets

4,203

4,262

Net assets

4,271

4,262

Shareholders' equity

Called up share capital

4,000

4,000

Retained earnings

271

262

Total shareholders' equity

4,271

4,262

Β 

Β 

Β 

Β 

Β 

Β Statement of cash flows

Β 

Β 

Year ended 31 March

2012

2011

UKβ‚€000

UKβ‚€000

Cash flows from operating activities

Cash used in operations

(210)

(68)

Financial income

152

169

Net cash (used in) generated from

operating activities

(58)

101

Cash flows from investing activities

Purchase of property, plant and equipment

(76)

-

Net cash used in investing activities

(76)

-

Β 

Net (decrease) increase in cash and

cash equivalents

(134)

101

Cash and cash equivalents

at beginning of year

4,257

4,156

Cash and cash equivalents at end of year

4,123

4,257

Β 

Β 

Β 

Β 

-ENDS-

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR UBVORUUAKUUR
Date   Source Headline
30th Sep 20247:00 amRNSHalf-year Report
27th Sep 20249:25 amRNSForm 8.5 (EPT/RI)
20th Sep 202411:21 amRNSForm 8.5 (EPT/RI)
19th Sep 202410:41 amRNSForm 8.5 (EPT/RI)
19th Sep 202410:13 amRNSPre-Harvest Statement
16th Sep 202410:26 amRNSForm 8.5 (EPT/RI)
11th Sep 20249:35 amRNSForm 8.5 (EPT/RI)
5th Sep 202411:09 amRNSForm 8.5 (EPT/RI)
4th Sep 20241:42 pmRNSForm 8.5 (EPT/RI)
3rd Sep 202411:42 amRNSForm 8.5 (EPT/RI)
2nd Sep 202410:16 amRNSForm 8.5 (EPT/RI)
27th Aug 20248:56 amRNSForm 8.5 (EPT/RI)
22nd Aug 20249:31 amRNSForm 8.5 (EPT/RI)
21st Aug 202410:13 amRNSForm 8.5 (EPT/RI)
20th Aug 20249:58 amRNSForm 8.5 (EPT/RI)
19th Aug 20249:59 amRNSForm 8.5 (EPT/RI)
16th Aug 202410:13 amRNSForm 8.5 (EPT/RI)
15th Aug 202411:01 amRNSForm 8.5 (EPT/RI)
12th Aug 202410:53 amRNSForm 8.5 (EPT/RI)
5th Aug 20241:35 pmRNSForm 8.3 - Andrew Weeber OPD
5th Aug 20241:35 pmRNSForm 8.3 - Paul Bentham OPD
5th Aug 20249:46 amRNSForm 8.5 (EPT/RI)
2nd Aug 20249:40 amRNSForm 8.5 (EPT/RI)
1st Aug 202412:44 pmRNSForm 8.5 (EPT/RI)
1st Aug 20249:48 amRNSForm 8.5 (EPT/RI)
31st Jul 202410:59 amRNSForm 8.5 (EPT/RI)
30th Jul 202410:11 amRNSForm 8.5 (EPT/RI)
25th Jul 20244:20 pmRNSForm 8 (OPD) - Gusbourne plc
25th Jul 202411:21 amRNSForm 8.5 (EPT/RI)
24th Jul 20241:05 pmGNWForm 8.3 - [GUSBOURNE PLC - Opening Disclosure - 22 07 2024] - (CGAML) - Updated
23rd Jul 20242:54 pmGNWForm 8.3 - [GUSBOURNE PLC - Opening Disclosure - 22 07 2024] - (CGAML)
23rd Jul 20241:58 pmRNSRule 2.9 Announcement
23rd Jul 202411:42 amRNSForm 8.5 (EPT/RI)
22nd Jul 20247:00 amRNSCommencement of Offer Period
14th Jun 20246:29 pmRNSResult of Annual General Meeting
23rd May 20247:00 amRNSAnnual Financial Report
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.